VXRT - VaxartAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $8.00 | Open | $8.05 |
| Volume | 12.36M | Market Cap | 555.64M |
| Yield | Last Dividend |
| The race for coronavirus treatments and ... | 07/01/20 |
| The summer will be a critical time for the race to develop effective coronavirus treatments and vaccines. Business Insider identified the nine most im... | |
| Inovio's 860% year-to-date rally takes a... | 06/30/20 |
| Inovio has rallied 860% year-to-date as investors bid up the company's stock in hopes of the successful development of a vaccine for COVID-19. On Tues... | |
| Thinking about buying stock in BioHiTech... | 06/29/20 |
| NEW YORK, June 29, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BHTG, VXRT, COTY, BLNK, and SHIP. To see how Investors... | |
| The Week Ahead In Biotech (June 28- July... | 06/28/20 |
| Biotech stocks went on a seesaw ride along with the broader markets in the week ended June 26. Yet there were some encouraging developments on the COV... | |
| Tiny biotechs are touting ties to Trump'... | 06/26/20 |
| The Trump administration's coronavirus vaccine program, called Operation Warp Speed, has been shrouded in secrecy since launching in May. Some tiny bi... | |
| Why Vaxart Stock Skyrocketed Today | The... | 06/26/20 |
| The coronavirus vaccine maker will participate in a government-funded study. | |
| A little-known biotech working on a COVI... | 06/26/20 |
| Vaxart, a small-cap biotechnology company focused on developing oral vaccines administered by tablet rather than injection, said on Friday that ??? | |
| Vaxart Rallies On Double Dose Of Positiv... | 06/26/20 |
| Shares of oral vaccine maker Vaxart Inc (NASDAQ: VXRT ) are on a strong two-day run after two announcements tied to coronavirus vaccine development. W... | |
| Why Vaxart, Inovio, and Sorrento Therape... | 06/25/20 |
| Investors are piling into coronavirus stocks as COVID-19 cases surge. | |
| Thinking about buying stock in IZEA Worl... | 06/25/20 |
| NEW YORK, June 25, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IZEA, VXRT, WKHS, TOPS, and DAL. To see how InvestorsO... | |
| Stock Alert: KindredBio Stock Up 16% On ... | 05/20/20 |
| Shares of Kindred Biosciences Inc. (KIN) are rising over 16% in pre-market today, after the company the biopharmaceutical company announced an agreeme... | |
| Coronavirus vaccine taken by tablet coul... | 05/15/20 |
| Dr Sean Tucker, chief scientific officer at Vaxart, has revealed that his company is trialling several vaccine tablets, which could be trailed in huma... | |
| The Daily Biotech Pulse: Pfizer Earnings... | 04/28/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) As... | |
| Vaxart Up on Pre-Clinical Data on Corona... | 04/22/20 |
| Vaxart's (VXRT) several COVID-19 vaccine candidates generate immune responses in pre-clinical studies. Stock rises. | |
| Pre-Market: Vaxart Pops 35% On Positive ... | 04/21/20 |
| Biotech Vaxart (VXRT) has announced positive pre-clinical results for its oral COVID-19 vaccine candidates, with several of the vaccine candidates gen... | |
| 10 Biotech Winners And Losers In Q1 | 04/01/20 |
| The quarter was brutal to say the least for most asset classes amid the coronavirus (COVID-19) pandemic. The S&P 500 Index was down about 20% for the ... | |
| Vaxart, Emergent Biosolutions Partner On... | 03/18/20 |
| Vaxart Inc (NASDAQ: VXRT ) shares were advancing Wednesday following an update from the company on its COVID-19 vaccine program. Vaxart said it has en... | |
| A Vaccine for Coronavirus? These 3 Healt... | 02/12/20 |
| Fear and uncertainty have gripped the global population as the number of confirmed coronavirus cases grows daily. What started in Wuhan, the capital o... | |
| Vaxart (VXRT) to Make Vaccines to Check ... | 02/03/20 |
| Vaxart (VXRT) begins a program to develop a vaccine candidate to counter the new coronavirus infection. Shares jump. | |
| Vaxart's stock rockets on heavy volume a... | 01/31/20 |
| Shares of Vaxart Inc. rocketed 54% on heavy volume in afternoon trading, putting them on track for the first close above the $1 mark in nearly 10 mont... | |
| Zacks: Vaxart Inc (NASDAQ:VXRT) Given Co... | 11/12/19 |
| Vaxart Inc (NASDAQ:VXRT) has been assigned a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that provide coverage for the sto... | |
| Armistice Capital Master Fund Purchases ... | 11/12/19 |
| Vaxart Inc (NASDAQ:VXRT) major shareholder Armistice Capital Master Fund acquired 200,000 shares of the company???s stock in a transaction that occurr... | |
| Vaxart : Hosting Key Opinion Leader Meet... | 11/06/19 |
| PDF Version Norovirus represents a $3+billion U.S. market opportunity SOUTH SAN FRANCISCO, Calif., Nov. 06, 2019 -- Vaxart, Inc. , a clinical-stage bi... | |
| The Daily Biotech Pulse: Enanta Aces Mid... | 09/26/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs S... | |
| The Daily Biotech Pulse: Glaukos To Buy ... | 08/08/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 7) A... | |
| Dosing underway in early-stage study of ... | 04/16/19 |
| No summary available. | |
| Vaxart down 22% on equity offering | 04/08/19 |
| No summary available. | |
| Microcaps dominate midday movers | 04/08/19 |
| No summary available. | |
| Vaxart +8% on completing dosing in norov... | 03/27/19 |
| No summary available. | |
| Vaxart closes $3M capital raise | 03/20/19 |
| No summary available. | |
| Buy rating | 04/30/20 |
| and raises Price Target from $3.00 to $7.00 | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Tech Trades | Tech Trades | 84.00 % | Follow |
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
